New Delhi, July 23 : Swaraj India on Monday welcomed the Supreme Court decision removing the blanket ban on peaceful protests in central Delhi including Jantar Mantar.
The party's Delhi state President Anupam said that the blanket ban imposed since last 10 months had made it difficult for common citizens, groups and organizations to make themselves heard to the government.
"It is a must for any democracy to have spaces in the capital city for collective expression of citizen's demands, suggestions and grievances. Jantar Mantar has over the decades acted as a safety valve of our democracy where suffering citizens and organizations from all over the country have come and expressed themselves. Denial of this right was a blatantly undemocratic act," he said.
"During the course of hearing in the court, our senior leader Prashant Bhushan, arguing the case, had pointed out that this blanket ban was undemocratic and violative of fundamental rights of citizens. The matter was being heard on a petition filed by Jansangathan, Majdoor Kisan Shakti Sangathan. Court has asked the Delhi Police Commissioner to frame rules regarding to this effect within two months," he said.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has identified 41 drug samples tested in central drug laboratories in November as 'not of standard quality' (NSQ), according to official sources. Additionally, 70 drug samples tested by state drugs testing laboratories during the same period were also classified as NSQ.
The classification as NSQ is based on the failure of drug samples to meet one or more specified quality parameters. Officials clarified that the findings pertain only to the specific batches tested and do not imply concerns about other drug products available in the market.
In November, two drug samples were found to be spurious. These samples, picked by the Bihar Drugs Control Authority and CDSCO Ghaziabad, were manufactured by unauthorised entities using the brand names of other companies.
Authorities regularly collaborate with state regulators to identify and remove NSQ and spurious medicines from the market to ensure public safety.